Natural Capsules (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Natural Capsules Limited |
|||
|
Price: ₹277.40 | ||
| 52 Week Low: ₹255.00 52 Week High: ₹400.00 |
|||
| Market Capital: 164.48 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Natural Capsules Share Price Target For 2024
- 1.1.1: Natural Capsules Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Natural Capsules Share Price Target For 2025
- 1.2.1: Natural Capsules Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Natural Capsules Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Natural Capsules Financial Performance
- 3.0.1: Is Natural Capsules A Good Buy For Long Term?
To predict the Natural Capsules's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Natural Capsules Share Price Target For 2024
The line chart displays the monthly closing prices of Natural Capsules with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Natural Capsules shares in 2024, see the table below.
Natural Capsules Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 287.8 (+3.74%) | Price Action: 17 Dec 2024 High |
| 2024 Target 2 | 284.95 (+2.72%) | Price Action: 21 Nov 2024 High |
| 2024 Target 1 | 281.0 (+1.29%) | Price Action: 14 Nov 2024 High |
| Current Price | 277.40 | Natural Capsules's share price as of 23 Dec 2024 |
| Stop Loss 1 | 275.33 (-0.75%) | Fibonacci Retracement Level 98.60% |
| Stop Loss 2 | 270.6 (-2.46%) | Price Action: 18 Nov 2024 High |
| Stop Loss 3 | 265.48 (-4.3%) | Fibonacci Retracement Level 40.00% |
Short-Term Technical Outlook
Current Technical Position: Natural Capsules is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹286.31 serves as the nearest technical reference point.
Historical Returns: 3-month: -11.44% | 6-month: -10.79% | 1-year: -22.21%
Natural Capsules Share Price Target For 2025
The line chart displays the monthly closing prices of Natural Capsules with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Natural Capsules shares in 2025, see the table below.
Natural Capsules Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 384.35 (+38.54%) | Price Action: Chart |
| 2025 Target 2 | 377.18 (+35.96%) | Price Action: Chart |
| 2025 Target 1 | 373.45 (+34.61%) | Fibonacci Extension Level 64.90% |
| Current Price | 277.40 | Natural Capsules's share price as of 23 Dec 2024 |
| Stop Loss 1 | 255.0 (-8.08%) | Price Action: Jun 2024 Low |
| Stop Loss 2 | 252.45 (-9%) | Price Action: Chart |
| Stop Loss 3 | 247.91 (-10.64%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Natural Capsules is currently trading near its 52-week low of ₹255, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -22.21% | 3-year: -15.21% | 5-year: +527.61%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Natural Capsules Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹277.40 | ||
| 2024 | ₹292.86 | +5.57% | ₹298.53 |
| 2025 | ₹250.58 | -14.43% | ₹292.37 |
| 2026 | ₹200.63 | -19.93% | ₹240.42 |
| 2027 | ₹196.89 | -1.86% | ₹219.23 |
| 2028 | ₹202.54 | +2.86% | ₹213.12 |
| 2029 | ₹215.03 | +6.16% | ₹218.74 |
| 2030 | ₹227.81 | +5.94% | ₹235.65 |
| 2031 | ₹215.51 | -5.39% | ₹226.19 |
| 2032 | ₹236.10 | +9.55% | ₹239.64 |
| 2033 | ₹225.67 | -4.41% | ₹242.06 |
| 2034 | ₹210.36 | -6.78% | ₹228.38 |
| 2035 | ₹257.14 | +22.23% | ₹261.00 |
| 2036 | ₹249.92 | -2.8% | ₹263.52 |
| 2037 | ₹248.79 | -0.45% | ₹335.22 |
| 2038 | ₹243.14 | -2.27% | ₹349.78 |
| 2039 | ₹334.46 | +37.55% | ₹339.48 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Natural Capsules Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 164.48 Crore | Market valuation of Natural Capsules's shares. |
| Revenue (TTM) | 151.28 Crore | Total revenue generated by Natural Capsules over the past twelve months. |
| Net Income (TTM) | +5.55 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +8.71% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +45.56% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+8.56% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.47 | Company's total debt divided by total shareholder equity. |
| Total Debt | 109 Crore | Sum of Natural Capsules's current & long-term financial obligations. |
| Total Cash | 1.94 Crore | Total amount of liquid funds available to Natural Capsules. |
Is Natural Capsules A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
